| 产品名称： | pFATPOT plasmid in S. cerevisiae ZYM-3 |
|---|---|
| 商品货号： | TS193465 |
| Designations： | pFATPOT plasmid in S. cerevisiae ZYM-3 |
| Species： | Homo sapiens, human |
| Depositors： | ZymoGenetics, Inc. |
| Applications： | produces protein alpha-1-antitrypsin (protease inhibitor) |
| Insert： | DNA: cDNA Gene product: alpha-1-antitrypsin (protease inhibitor) PI Alleles: G3, A1, A2, B1, B2, D2, G1, G2, J2, N1, N2, C1, C2, D1, J1 Target Gene: alpha-1-antitrypsin (protease inhibitor) |
| Media： | ATCC® Medium 1245: YEPD |
| Biosafety Level： | 1
Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country. |
| Comments： | Strain E18 transformed with pFATPOT Production of site specific alpha-1-antitrypsin The POT1 sequence can be removed from pFATPOT by a SalI/BamHI double digest as a fragment of approximately 1.6 kb. The wild-type alpha-1-antitrypsin gene can be removed by a BamHI/XbaI double digest. The alpha-1-antitrypsin gene is under the regulation of the Saccharomyces cerevisiae TPI promoter, and is followed by the Saccharomyces cerevisiae TPI terminator. The vector contains a pMB1 and 2 micron replicon. |
| References： | Murray MJ, Kelly JD. Expression of biologically active PDGF analogs in eucaryotic cells. US Patent 4,766,073 dated Aug 23 1988 Insley MY, Kawasaki G. Site specific mutagenesis in alpha1-antitrypsin. US Patent 4,711,848 dated Dec 8 1987 Murray MJ, Kelly JD. Biologically active mosaic proteins. US Patent 4,849,407 dated Jul 18 1989 |
| Disclosure： | This material is cited in a US or other Patent and may not be used to infringe the claims. Depending on the wishes of the Depositor, ATCC may be required to inform the Patent Depositor of the party to which the material was furnished. This material may not have been produced or characterized by ATCC. |
产品中心 Product Center
联系我们CONTACT US
-
0574-87917803
24小时服务热线 -
testobio@163.com
销售邮箱 -
浙江省宁波市高新区晶辉路866弄33号智造港E4幢3楼
地址
联系方式
-
章丽敏
17757489010 -
朱静
18067106081 -
李晴
18067408036 -
李晶晶
13375187189 -
周雪
13372109301
| 产品名称： | pFATPOT plasmid in S. cerevisiae ZYM-3 |
|---|---|
| 商品货号： | TS193465 |
| Designations： | pFATPOT plasmid in S. cerevisiae ZYM-3 |
| Species： | Homo sapiens, human |
| Depositors： | ZymoGenetics, Inc. |
| Applications： | produces protein alpha-1-antitrypsin (protease inhibitor) |
| Insert： | DNA: cDNA Gene product: alpha-1-antitrypsin (protease inhibitor) PI Alleles: G3, A1, A2, B1, B2, D2, G1, G2, J2, N1, N2, C1, C2, D1, J1 Target Gene: alpha-1-antitrypsin (protease inhibitor) |
| Media： | ATCC® Medium 1245: YEPD |
| Biosafety Level： | 1
Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country. |
| Comments： | Strain E18 transformed with pFATPOT Production of site specific alpha-1-antitrypsin The POT1 sequence can be removed from pFATPOT by a SalI/BamHI double digest as a fragment of approximately 1.6 kb. The wild-type alpha-1-antitrypsin gene can be removed by a BamHI/XbaI double digest. The alpha-1-antitrypsin gene is under the regulation of the Saccharomyces cerevisiae TPI promoter, and is followed by the Saccharomyces cerevisiae TPI terminator. The vector contains a pMB1 and 2 micron replicon. |
| References： | Murray MJ, Kelly JD. Expression of biologically active PDGF analogs in eucaryotic cells. US Patent 4,766,073 dated Aug 23 1988 Insley MY, Kawasaki G. Site specific mutagenesis in alpha1-antitrypsin. US Patent 4,711,848 dated Dec 8 1987 Murray MJ, Kelly JD. Biologically active mosaic proteins. US Patent 4,849,407 dated Jul 18 1989 |
| Disclosure： | This material is cited in a US or other Patent and may not be used to infringe the claims. Depending on the wishes of the Depositor, ATCC may be required to inform the Patent Depositor of the party to which the material was furnished. This material may not have been produced or characterized by ATCC. |
